Eagle Asset Management’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-155,972
Closed -$1.87M 550
2022
Q4
$1.87M Sell
155,972
-4,181
-3% -$50.2K 0.01% 435
2022
Q3
$3.36M Buy
160,153
+61,422
+62% +$1.29M 0.02% 393
2022
Q2
$3.06M Sell
98,731
-88,635
-47% -$2.75M 0.02% 410
2022
Q1
$7.69M Sell
187,366
-7,881
-4% -$324K 0.04% 317
2021
Q4
$8.81M Buy
195,247
+44,032
+29% +$1.99M 0.04% 328
2021
Q3
$7.57M Sell
151,215
-6,003
-4% -$301K 0.03% 356
2021
Q2
$9.9M Sell
157,218
-360,820
-70% -$22.7M 0.04% 326
2021
Q1
$41.7M Sell
518,038
-49,946
-9% -$4.02M 0.18% 173
2020
Q4
$50.9M Buy
567,984
+1,256
+0.2% +$113K 0.29% 123
2020
Q3
$59.1M Buy
566,728
+25,323
+5% +$2.64M 0.3% 125
2020
Q2
$40.8M Buy
541,405
+308,241
+132% +$23.3M 0.23% 152
2020
Q1
$13.5M Sell
233,164
-49,694
-18% -$2.88M 0.08% 237
2019
Q4
$15.3M Sell
282,858
-29,366
-9% -$1.58M 0.07% 253
2019
Q3
$16.3M Buy
312,224
+5,592
+2% +$292K 0.08% 243
2019
Q2
$14.8M Buy
306,632
+97,374
+47% +$4.7M 0.08% 254
2019
Q1
$10.6M Buy
209,258
+28,473
+16% +$1.44M 0.06% 299
2018
Q4
$10.7M Buy
180,785
+34,425
+24% +$2.04M 0.07% 282
2018
Q3
$9.63M Sell
146,360
-1,882
-1% -$124K 0.05% 342
2018
Q2
$7.48M Sell
148,242
-11,193
-7% -$565K 0.04% 370
2018
Q1
$8.39M Buy
159,435
+15,833
+11% +$834K 0.05% 338
2017
Q4
$6.67M Sell
143,602
-109,771
-43% -$5.1M 0.04% 383
2017
Q3
$10.5M Buy
253,373
+4,888
+2% +$202K 0.06% 329
2017
Q2
$8.43M Buy
248,485
+11,114
+5% +$377K 0.05% 345
2017
Q1
$6.89M Sell
237,371
-6,459
-3% -$188K 0.04% 376
2016
Q4
$8.01M Buy
243,830
+3,789
+2% +$124K 0.05% 344
2016
Q3
$7.57M Sell
240,041
-175,484
-42% -$5.53M 0.05% 355
2016
Q2
$11.7M Sell
415,525
-3,762
-0.9% -$106K 0.08% 303
2016
Q1
$15.2M Sell
419,287
-5,018
-1% -$182K 0.11% 262
2015
Q4
$17M Sell
424,305
-198,259
-32% -$7.93M 0.11% 246
2015
Q3
$17.7M Buy
622,564
+112,014
+22% +$3.19M 0.12% 227
2015
Q2
$16.8M Buy
510,550
+226,413
+80% +$7.46M 0.09% 256
2015
Q1
$8.17M Buy
284,137
+7,364
+3% +$212K 0.05% 361
2014
Q4
$7.54M Buy
+276,773
New +$7.54M 0.04% 369